MDM2 and osteosarcoma: MDM2 rs1690916 was not significantly associated with the risk of osteosarcoma in the main analysis but in the leave-one-out sensitivity analysis, rs1690916 was significantly associated with a decreased risk of osteosarcoma under the allele and the dominant model.